0001570562-20-000094.txt : 20200515
0001570562-20-000094.hdr.sgml : 20200515
20200515200006
ACCESSION NUMBER: 0001570562-20-000094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200513
FILED AS OF DATE: 20200515
DATE AS OF CHANGE: 20200515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Avelar Rui
CENTRAL INDEX KEY: 0001432063
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 20887415
MAIL ADDRESS:
STREET 1: 1618 STATION STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6A 1B6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
4
1
wf-form4_158958718809777.xml
FORM 4
X0306
4
2020-05-13
0
0001570562
Evolus, Inc.
EOLS
0001432063
Avelar Rui
520 NEWPORT CENTER DR.
SUITE 1200
NEWPORT BEACH
CA
92660
0
1
0
0
See Remarks
Common Stock
2020-05-13
4
A
0
40000
0
A
136802
D
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
Chief Medical Officer and Head of Research & Development
/s/ Jeffrey J. Plumer, as attorney-in-fact for Rui Avelar
2020-05-15